Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bryostatin-1 and Cisplatin in Metastatic Gastric Cancer
NCT00006389Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Oct 2000
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bryostatin-1 in gastric cancer (GC), sponsored by National Cancer Institute. Primary endpoint: Observed Response Rate. Started Oct 2000; status: completed.
02
Drugs
bryostatin-1
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00006389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006389.